Table 37:
Net Budget Impact of Funding Continuous Glucose Monitoring in Ontario by Age Group—Funding for Insulin, Pump, Strips, and 75% of Sensor Costs
| Age,a y | Year 1, $ | Year 2, $ | Year 3, $ | Year 4, $ | Year 5, $ |
|---|---|---|---|---|---|
| Funding CGM Based on a Conservative Projection of a 20% Annual Increase | |||||
| All ages | 6,258,114 | 7,212,880 | 8,616,558 | 10,212,713 | 11,746,912 |
| 0–24 | 1,738,689 | 2,003,952 | 2,393,935 | 2,837,394 | 3,263,640 |
| 25–65 | 3,397,447 | 3,915,777 | 4,677,815 | 5,544,347 | 6,377,243 |
| 65+ | 1,121,977 | 1,293,151 | 1,544,808 | 1,830,972 | 2,106,029 |
| Funding CGM for Entire Population With Hypoglycemia Unawareness | |||||
| All ages | 62,186,324 | 63,630,543 | 64,296,591 | 64,842,725 | 65,295,437 |
| 0–24 | 17,499,740 | 17,721,986 | 17,688,562 | 17,646,273 | 17,613,612 |
| 25–65 | 33,898,320 | 34,600,771 | 34,804,315 | 34,934,408 | 34,960,287 |
| 65+ | 10,788,265 | 11,307,785 | 11,803,714 | 12,262,045 | 12,721,538 |
| Funding CGM for Entire Type 1 Diabetes Population | |||||
| All ages | 248,745,298 | 254,522,171 | 257,186,365 | 259,370,901 | 261,063,447 |
| 0–24 | 69,998,960 | 70,887,946 | 70,754,249 | 70,585,090 | 70,421,580 |
| 25–65 | 135,593,278 | 138,403,086 | 139,217,260 | 139,737,631 | 139,776,924 |
| 65+ | 43,153,060 | 45,231,139 | 47,214,856 | 49,048,180 | 50,864,943 |
Abbreviations: CGM, continuous glucose monitoring; NBI, net budget impact.
a
Ages 0–24 years, full funding of blood glucose test strips (annual cost $1,243); 25–65 years, strips funded to a maximum $920; 65+ years, full funding of strips and $170 grant for syringes and needles.